Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Weighted Average)
Others
Ratios

Pulse Biosciences (PLSE) Non Operating Income (2020 - 2025)

Pulse Biosciences has reported Non Operating Income over the past 6 years, most recently at -$19000.0 for Q3 2025.

  • Quarterly results put Non Operating Income at -$19000.0 for Q3 2025, down 101.95% from a year ago — trailing twelve months through Sep 2025 was $5.0 million (up 109.39% YoY), and the annual figure for FY2024 was $2.7 million, up 95.89%.
  • Non Operating Income for Q3 2025 was -$19000.0 at Pulse Biosciences, down from $1.1 million in the prior quarter.
  • Over the last five years, Non Operating Income for PLSE hit a ceiling of $2.7 million in Q4 2024 and a floor of -$517000.0 in Q2 2021.
  • Median Non Operating Income over the past 5 years was $167500.0 (2022), compared with a mean of $393500.0.
  • Biggest five-year swings in Non Operating Income: tumbled 7433.33% in 2022 and later surged 5000.0% in 2023.
  • Pulse Biosciences' Non Operating Income stood at -$6000.0 in 2021, then tumbled by 7433.33% to -$452000.0 in 2022, then soared by 232.74% to $600000.0 in 2023, then skyrocketed by 346.67% to $2.7 million in 2024, then tumbled by 100.71% to -$19000.0 in 2025.
  • The last three reported values for Non Operating Income were -$19000.0 (Q3 2025), $1.1 million (Q2 2025), and $1.2 million (Q1 2025) per Business Quant data.